Clinical Social Work and the Biomedical Industrial Complex by Gomory, Tomi et al.
The Journal of Sociology & Social Welfare
Volume 38
Issue 4 December Article 8
2011
Clinical Social Work and the Biomedical Industrial
Complex
Tomi Gomory
Florida State University
Stephen E. Wong
Florida International University
David Cohen
Florida International University
Jeffrey R. Lacasse
Arizona State University
Follow this and additional works at: https://scholarworks.wmich.edu/jssw
Part of the Clinical and Medical Social Work Commons, Social Welfare Commons, and the Social
Work Commons
This Article is brought to you for free and open access by the Social Work at
ScholarWorks at WMU. For more information, please contact
maira.bundza@wmich.edu.
Recommended Citation
Gomory, Tomi; Wong, Stephen E.; Cohen, David; and Lacasse, Jeffrey R. (2011) "Clinical Social Work and the Biomedical Industrial
Complex," The Journal of Sociology & Social Welfare: Vol. 38 : Iss. 4 , Article 8.
Available at: https://scholarworks.wmich.edu/jssw/vol38/iss4/8
Clinical Social Work and the
Biomedical Industrial Complex
Tomi GOMORY
Florida State University
College of Social Work
STEPHEN E. WONG
DAVID COHEN
Florida International University
School of Social Work
JEFFREY R. LACASSE
Arizona State University
School of Social Work
This article examines how the biomedical industrial complex has
ensnared social work within a foreign conceptual and practice
model that distracts clinical social workers from the special assis-
tance that they can provide for people with mental distress and
misbehavior. We discuss: (1) social work's assimilation of psychi-
atric perspectives and practices during its pursuit of professional
status; (2) the persistence of psychiatric hospitalization despite its
coercive methods, high cost, and doubtful efficacy; (3) the increas-
ing reliance on the Diagnostic and Statistical Manual of Mental
Disorders, despite its widely acknowledged scientific frailty; and
(4) the questionable contributions of psychoactive drugs to clinical
mental health outcomes and their vast profits for the pharmaceu-
tical industry, using antipsychotic drugs as a case example. We
review a number of promising social work interventions overshad-
owed by the biomedical approach. We urge social work and other
helping professions to exercise intellectual independence from
the reigning paternalistic drug-centered biomedical ideology in
mental health and to rededicate themselves to the supportive, edu-
cative, and problem-solving methods unique to their disciplines.
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According to the National Association of Social Workers
(NASW), clinical social workers mainly focus on "the mental,
emotional, and behavioral well-being of individuals, couples,
families, and groups," are essential in settings such as health
centers and hospitals, substance use treatment programs,
schools, agencies for children or the aged, employee assistance
programs, and private practice, and "represent the largest
group of behavioral health practitioners in the nation" (2005,
p. 7). Based on data from the U.S. Bureau of Labor Statistics
(2010) and Whitaker and Arrington (2008), one can estimate
that approximately 40% of the 642,000 social workers in the
U.S., or 255,000 individuals, practice clinical social work.
Over the past three decades, the medicalization of distress
and misbehavior has exploded. In professional and popular
forums, problems previously attributed to environmental,
social, and personal factors-such as poverty, disintegration of
family and community, grueling work, and abusive or neglect-
ful childhoods-have been increasingly attributed to brain dys-
functions stemming from as-of-yet-unconfirmed genetic and
chemical defects (Conrad, 2007; Moynihan & Cassels, 2005).
Some studies suggest that social work education and practice
shifted from understanding how personal-historical-ecologi-
cal-contextual factors may bring about behavioral problems,
to viewing severe distress and disability as manifestations of
biological diseases defined by the successive editions of the
Diagnostic and Statistical Manual of Mental Disorders (DSM)
(Lacasse & Gomory, 2003). The shift is accompanied by clinical
social workers' use of descriptive psychiatric labels as expla-
nations for their clients' problems (Frazer, Westhuis, Daley, &
Phillips, 2009) and, in academic social work writings, by an ap-
parent acceptance and a dearth of critical analyses of the worth
of psychotropic drugs (Cohen, 2010). For certain authors, some
of these developments indicate that clinical social workers are
appropriately "making research-based assessments of mental
illnesses etiology" (Walsh, Green, Matthews, & Bonucelli-
Puerto, 2005, p. 43). We argue otherwise in this paper, suggest-
ing that the redefinition of the causes of disturbing behavior
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along the lines of current psychiatric practice is part of a larger
ideological and institutional project that is only loosely tied to
science. We also argue that it has narrowed the options of clini-
cal social workers and other helping professionals.
Professional validation and survival might appear as
motives for clinical social work's turn to the view that serious
distress, psychosocial disability, and misbehavior are manifes-
tations of somatic problems requiring primarily medical solu-
tions. In this era of relative retrenchment of federal and state
spending away from human services and toward health care
(Bielefeld & Chu, 2010), the activities of social workers would
continue to benefit from official standing and public and third-
party funding within the biomedical-industrial complex and
existing welfare state.
When Relman (1980) introduced the phrase "biomedical
industrial complex" to echo President Dwight Eisenhower's
famous 1960 warning about the influence of the military-in-
dustrial complex, he wished to emphasize the influence of
large corporations on the medical system. Later writers, focus-
ing on its psychiatric portion or counterpart and emphasizing
its ideological elements, such as medicalization, described a
mental health-industrial complex (Duhl, Cummings, & Hynes,
1987), a psychiatric-industrial complex (Carpenter, 2001), or
a psychopharmaceutical-industrial complex (Breggin, 1997;
Murray, 2009). In accord with these authors, we use the term to
refer to the reinforcing and interlocking connections between
the pharmaceutical, biotechnological, and medical industries
that-together with academic experts in the helping profes-
sions, governmental funding and regulatory bureaucracies,
such as the National Institute of Mental Health (NIMH) and
the Food and Drug Administration (FDA), and professional
and family lobbies-promote and support a biomedical model
of psychosocial distress and disability. Spending in the U.S. on
mental health and substance abuse has been forecast to reach
$239 billion by 2014, of which $72 billion is expected to be for
psychotropic drugs (Levit et al., 2008).
Critics of the biomedical complex observe that over the
past fifty years it has monopolized mental health practices
to the detriment of its ostensible beneficiaries. Its primary
purpose seems to be "biomedical dominance" (Carpenter, 2001,
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p. 70), the successful inculcation of the view that a medical-
ized approach (conceptual, scientific, clinical, institutional) to
psychosocial distress, disability, and disapproved behavior is
valid and is the best approach for everyone. Critics document
that the approach obscures the differential benefits accruing
especially to the leading players, theorized in most discussions
to be large private corporations (especially but not exclusively
pharmaceutical) and their allies in politics, the professions,
and academia. These benefits translate into money, and there-
fore influence to recast all the issues involved, "to the extent of
altering public perceptions as to what is occurring and why"
(Turnock, 2009, p. 136). Some policy analysts have noted how
heads of corporations benefit lavishly but illicitly from the bio-
medical industrial complex (e.g., Cassels, 2009), and at least
one clinician (Murray, 2009), has argued that the psychophar-
maceutical-industrial complex leads many clients to adopt
and internalize "disease-model messages ... in ways similar
to cult indoctrination" (p. 283), that is, impervious to evidence
and experience. These observations illustrate the complexity
of the system; they are not meant to promote a conspiracy-
theory-type of explanation. Our use of psychiatric-industrial
complex and associated terms is meant to re-focus attention of
social workers on the explicit and implicit functions and on the
dynamic nature of a very large social system, and of their roles
in it. It is also meant to highlight interconnections between the
constituent ideologies, professions, client populations, treat-
ments, and institutions of the system, as well as connections
between it and other large systems, such as criminal justice,
welfare, education, and the military.
This paper's purpose is to examine and critique the bio-
medical industrial complex's power to define the nature,
causes, and responses to psychosocial distress, disability, and
disapproved behavior as physical diseases. It also posits that
this unopposed authority threatens the well-being of distressed
persons and suppresses innovative solutions to the perennial
challenge of disturbing behavior that might not comport with
this belief. Social workers delivering clinical services, by and
large, have sought to align with and assimilate within psychi-
atry's explanatory framework without carefully analyzing its
assumptions and outcomes. We think this has led to a loss of
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intellectual and practical independence among social workers.
In the hope of spurring readers to scrutinize existing systems
of care and their compatibility with the values of social work,
we review clinical social work's ancillary role to psychiatry
and discuss the contemporary functions of the psychiatric hos-
pital, of the DSM, and of psychoactive medications as elements
in the modern psychiatric-industrial complex. We conclude by
offering suggestions for social workers and other profession-
al helpers considering employment in or currently working
in mental health systems. In this paper we synthesize and
analyze research and evidence culled from the publicly avail-
able mainstream literature. We are puzzled that we have not
found previous academic social work publications highlight-
ing the enormous threat that, in our judgment, scientifically
untenable claims of the psychiatric-industrial complex present
to both the well-being of our clients and to the professional
independence and effectiveness of clinical social workers.
When we use terms such as mental disorder and mental
illness in this paper, we simply refer to the many different
behaviors that have become the targets of the mental health
care system. We imply no agreement with the idea that these
problems are at root biological, that they represent distinct
clinical entities as characterized by the DSMs since 1980, or
even that they should be separated conceptually as psycho-
pathology from other problems of living. We think that they
include at least two broad types of problems that should be
distinguished, although people often manifest both simultane-
ously. On the one hand, there is distress: usually situational,
life-stage-related difficulties in coping with life's demands that
manifest as impairments in personal or interpersonal function-
ing, and for which people seek or accept help. On the other
hand, there is misbehavior: deviant, offensive or socially disrup-
tive behaviors that mobilize social groups to restrain the un-
cooperative individual. Failure to distinguish between these
two categories and the differential societal response to each,
conflates the perhaps empirically irreconcilable dual mandates
to help clients and protect society under the single rubric of
"mental health practice." This categorical mistake of not dis-
tinguishing therapeutic engagement from coercive police or
managerial authority has long been a cause of ethical dilemmas
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faced by public psychiatric social workers. It also fits with the
recent patterns of transformation of the psychiatric-industrial
complex following the downsizing of the large state mental
hospitals during the 1970s and beyond.
Social Work's Historical Alliance with Psychiatry
When a shift occurred from the universal explanatory par-
adigm of religion to that of science in the 17th and 18th cen-
turies, American society also began to view dependence and
charity more rationally and critically, and by the 19th century
took "steps toward a science of social welfare and a profession
of social work" (Leiby, 1978, p. 43). This paralleled the devel-
opment of almshouses, reformatories and hospitals as more
humane and efficient institutions to deal with dependent pop-
ulations, including the insane. The first almshouse in America
was built in Boston in 1662, the first hospital in Philadelphia in
1752, and the very first hospital exclusively for mad people in
Williamsburg, Virginia in 1773 (Grob, 1973).
The development of insane asylums took a sharp turn in the
mid-1800s, when Dorothea Dix, a social reformer appropriated
as a pioneer both by social work and psychiatry, championed
the creation of state-run institutions for the insane as alterna-
tives to detaining them in penal institutions. Building upon
her claim that insanity was "as curable as a cold or a fever"
(cited in Scull, 1981, p. 156) if managed according to the prin-
ciples of moral treatment (a combination of detention, labor,
and re-education), she aggressively lobbied state legislatures
for funds to build public insane asylums (Lightner, 1999), and
32 state mental hospitals were founded or enlarged as a result
of her efforts (Leiby, 1978). Historians agree that Dix "was not
above employing exaggerated rhetoric or embellishing facts"
(Grob, 1994, p. 47) and that her statistics were inaccurate and
unreliable (Rothman, 1990). Gollaher (1995, pp. 434-437) has
shown how some then contemporary critics could be wither-
ing of the asylum movement and of Dix's uncritical promotion
of it. The mostly well-intended actions of Dix and her allies,
the emerging 19th century medical superintendents of insane
asylums, and the uses they made of data are early examples
of reforms and paradigm shifts in mental health justified on
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the basis of largely (but not universally) uncritically accepted
outcome claims made by social reformers and others to gain or
extend professional turf (Abbott, 1988).
Eventually, any therapeutic value of moral treatment and
its environment, the asylum, could no longer be sustained.
When Dix began her campaign in the early 1840s, less than
3,000 people lived in public and private asylums. Fifty years
later, there were 74,000 residents just in the public facilities
(Whitaker, 2002). The latter population grew to consist of the
mad, the syphilitics, the alcoholics and the senile elderly, in-
exorably turning the system away from curing to warehous-
ing. This development paralleled the medicalization of these
institutions (Whitaker, 2002, ch. 2).
It is well known that "social work is one of society's tools
for securing conformity and controlling deviant individuals
and groups" (Hutchinson, 1992, p. 126). Psychiatry, however,
has been the prominent profession for these social manage-
ment purposes. Much like psychiatry, social work, from its
origin, focused on social pathology and used paternalistic
interventions. Both groups skirmished with neurologists and
the nascent applied psychologists in the early 20th century for
professional control of "the Personal Problems Jurisdiction"
described by Abbott (1988, pp. 280-314). Neither group had
genuine scientific techniques of their own, but psychiatry
won out because, on the basis of its historical identification
as a medical specialty, it drew upon the age-old tradition and
emerging breakthroughs of physiological medicine. More im-
portant, by using coercion and detention and defining them
as treatment, psychiatry acquired an indispensable function in
mutating societies increasingly based on the rule of law: the
extra-legal incarceration of the insane and adult dependent
populations-a management function that has remained intact
to this day. In this endeavor, clinical social workers were rele-
gated to being psychiatry's "handmaidens," probably because
most practitioners were women and, as Abraham Flexner
told them in 1915, lacked sufficient educationally transmis-
sible techniques and individual responsibility in their work to
qualify as professionals (Trattner, 1979).
The effort to become a full-fledged profession provid-
ed incentives for social work to value its association with
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psychiatry and to utilize the latter "as an important working
model and standard of comparison" (Lubove, 1983, p. 55). One
can imagine that pioneer social workers did not wish to be
psychiatrists and anticipated a rational, scientific social work
profession whose practitioners worked for the moral, physi-
cal, and social betterment of deprived individuals, families,
and groups. But it is difficult to imagine that they could look
elsewhere than to psychiatry-with its mix of authoritarian-
ism, history taking, advice giving, and medical language, for
example-as they sought professional status. The alignment
provided both a semblance of a scientific approach to enhance
social work's hoped-for professional clout, and actual settings
that could hire social workers. But it also led to social work's
subordination to psychiatric authority and to its subsequent
direct role in coercing clients, as no recognizable contractual
psychiatry yet existed. Already by 1906, Dr. James J. Putnam
of Boston's Psychopathic Hospital hired social workers to visit
patients' homes and establish "friendly relation[s]" with them
and their families "as a means of making [the physician's] di-
rections to them effective" (Lubove, 1983, p. 63). (Putnam's use
of social workers to extend psychiatric influence in the home
of the client is a precursor to today's coercive assertive com-
munity treatment used with the severely mentally disturbed
[see Gomory, 2005]).
Perhaps more than anyone, the pioneer social worker Mary
Richmond cemented the intellectual alliance of social work
with psychiatry by developing the notion of individual treat-
ment (casework), the sine qua non of the profession. According
to Lubove (1983), Richmond "singled out the combination of
Juvenile Court and Psychopathic Institute (along with charity
organization and medical social work) as decisive factors in the
evolution of casework" (p. 45). This further identified social
work intervention with paternalism, the medical model, and
medical settings (Kirk, Siporin, & Kutchins, 1989, pp. 296-297).
In her classic Social Diagnosis, a major response to Flexner's
charges, Richmond (1917) changed the name of casework-
ers' method from investigation to diagnosis, in order "to make
advances toward a professional standard" (Richmond, 1917,
p. 26). Struggling for professional acceptance, social workers
strove to resemble medicine, by doing diagnosis and treatment
rather than investigations.
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A number of social work academics have argued that
during the middle decades of the century, "[tlhe hunches and
hypotheses of Freud, Jung, Rank and Adler combined to stim-
ulate ... [a] 'psychiatric deluge' in social work" (Reamer, 1992,
p. 14). This argument is misleading if it implies that psychiat-
ric influence was not always present in clinical social work, or
that the latter was unique in being strongly influenced by psy-
choanalytic ideas. Although many clinical social workers at
that time tried to direct their gaze to inner personality dynam-
ics, as psychoanalytic theory requires, these practitioners also
applied the gamut of psychiatric approaches, as they had in
earlier decades (Alexander, 1972). Undoubtedly, some clients
benefitted. But in the service of social control, casework also
led to stigmatizing of some clients' lives and behavior (Dolnick,
1998). Margolin (1997) cites striking passages from several ar-
ticles in social work journals in the 1960s where, especially if
they were poor, clients were described by social workers as
both emotionally and morally undeveloped.
Fifty years later, the mental health system has vastly ex-
panded in breadth and depth. Today's psychiatric deluge in
clinical social work is still about psychiatric thinking-al-
though within a therapeutic landscape now dominated by
psychoactive drugs.
Psychiatric Hospitals and Inpatient Treatment
Like any social reform, Dorothea Dix's campaign for build-
ing state mental hospitals had unanticipated consequenc-
es. Instead of ameliorating the difficulties of the mad, state
asylums evolved into large warehouses for society's unwant-
ed. Their population rose from 332,000 in the early 1930s to
559,000 twenty years later (Mechanic, 1990). Although much
care of the people diagnosed with severe mental disorders
did shift to the community starting in the late 1960s, in one
of the largest shifts in American mental health policy, it con-
tinued to advance physical treatments for dimly understood
and presumed diseases of the nervous system. Assumptions
that governed the old state hospital treatments continue to un-
dergird new community mental health services. Indeed, one
key justification for implementing the previously mentioned
assertive community treatment was that it would serve as a
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"hospital without walls" (Bond, Drake, Mueser, & Latimer,
2001, p. 146).
Today, the psychiatric units of medical-surgical hospitals
have become the major mental health crisis centers of the nation.
In the latest available data as of this writing, Manderscheid
and Berry (2006, p. 205) report that 50% of the 2.2 million psy-
chiatric inpatient admissions, readmissions, and returns from
leave in 2002 took place in non-federal general hospitals while
only about 11% occurred in state and county mental hospitals.
So, while policy makers, professionals, and the public saw the
need for the institutional reform of the state hospital system
and community mental health treatment, the interplay among
the various elements of the biomedical-industrial complex,
along with the continued need to manage this population, has
led to a system of care that is today more medical in both ap-
proach and setting.
Just as the former state hospitals relied on the unique
state-sanctioned power of psychiatrists to force people into
locked wards, psychiatric crisis management today also rests
substantially on coercion. In this connection, it is important
to note that American national data on involuntary psychiat-
ric examinations and detentions are extremely sparse. Using
the Medline database, we could not locate a single such study
published in the last 20 years, and our queries to national
experts were similarly unsuccessful. This absence possibly
contributes to misperceptions concerning the actual extent of
involuntary psychiatric interventions. Using 2006 involuntary
detention data for adults from California (California Health
& Human Services Agency, 2009) and 2006 involuntary psy-
chiatric examination data for adults in Florida (Christy, 2007),
we found a very similar rate for both activities (44.6 and 49.3
per 10,000 persons in Florida and in California, respectively).
Extrapolating from the lower figures, we estimate that 1.37
million people are subjected to involuntary psychiatric deten-
tion in the U.S. in a given year. This would mean that 62% of
the nation's annual 2.2 million psychiatric inpatient admis-
sions, readmissions, and returns from leave are officially in-
voluntary (in addition to an unknown proportion of officially
voluntary hospitalizations).
Inpatient treatment, based on 24-hour-a-day medical
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care and a hospital infrastructure, is a costly undertaking. It
absorbed $41.4 billion of the 100.3 billion, or 41%, spent on
mental health treatment in 2003, the latest year for which data
are available (Manderscheid & Berry, 2006; Levit et al., 2008).
However, less than 1% of the general population will ever be
hospitalized (Bourdon, Rae, Narrow, Manderscheid, & Regier,
1994). Among the misallocation of current resources to these
facilities that may require reconsideration is the utilization
of professional social workers. In 1986, with approximately
218,000 inpatient residents, 21,000 social workers provided
services at these facilities. By 2000, however, with only 139,000
inpatient residents, the number of social workers employed
had almost doubled to 37,000 (Manderscheid & Berry 2006,
p. 213). Perhaps there are good reasons for this apparently
disproportional employment of social workers in coercive in-
patient settings-good pay and benefits, more serious prob-
lems of the current hospitalized population requiring higher
worker-to-client ratios-but we have found no discussion in
the social work literature of either the questionable ethics of
the use of coercion or of the potential misallocation of clinical
social workers.
Given the routine application of force for hospitalization
and treatment compliance, and the disproportionate share
of mental health funds and professional services funneled
toward such a small segment of the population, one might
expect to find compelling data showing that psychiatric hos-
pital treatment improves the lives of patients. This is not the
case (Kiesler & Simpkins, 1993; Pfeiffer, 1990; Pottick, Hansell,
Gaboda, & Gutterman, 1993). An extensive review by Kiesler
and Sibulkin (1987) of randomized controlled studies conduct-
ed from 1967-1979 comparing mental hospitalization to some
alternative intervention found no differences or the alterna-
tive outperforming hospitalization on outcomes of readmis-
sion, psychiatric symptoms, employment, social functioning,
and patient satisfaction. To our knowledge, no similar com-
prehensive systematic review has been published since Kiesler
and Sibulkin's. However, more recent research comparing
inpatient psychiatric hospitalization to day hospital/crisis
respite care (Sledge et al., 1996), a Soteria-like alternative resi-
dential program (Fenton, Mosher, Herrell, & Blyler, 1998), a
145
Journal of Sociology & Social Welfare
consumer-managed residential program (Greenfield, Stone-
king, Humphreys, Sundby, & Bond, 2008), and a variety of
community-based services (Lloyd-Evans, Slade, Jagielska, &
Johnson, 2009), also failed to demonstrate superior outcomes
for inpatient hospitalization as compared to less-restrictive
and usually consumer-preferred alternatives.
In sum, though it serves only a tiny fraction of troubled
persons in our country and alternatives have been shown to
produce better outcomes for patients, inpatient hospital treat-
ment takes almost half of the over 100 billion dollars of annual
mental health spending in the modern mental health system.
More importantly, and less discussed, psychiatric hospitaliza-
tion continues to be made possible by explicit coercion, a prob-
lematic ethical and political issue that is difficult to examine or
discuss comprehensively, due to the paucity of available data.
These considerations undermine the argument that it consti-
tutes a value neutral, science/evidence-based form of medical
treatment.
The DSM and the Political Economy of Social Work
The Diagnostic and Statistical Manual of Mental Disorders
(DSM) of the American Psychiatric Association (APA) is the
"bible" for mental health professionals. Insurance companies
and managed-care organizations require its codes and diagno-
ses for reimbursement or payment of mental health services.
Is this because the DSM constitutes a valid diagnostic tool to
identify mental disorders? Clearly not. The 1980 DSM-III was
created by the neo-Kraepelinian branch of American psychia-
try, strictly adhering to the view that psychiatry is a branch
of medicine that deals with people who are physically sick,
that distinct boundaries exist between mental disorder and
normality, and that diagnostic systems needed codification
to improve reliability and validity (Klerman, 1978). However,
when the APA in 2002 explained the need for a fifth revision
of the manual, it acknowledged the lack of any evidence sup-
porting claims of biological etiology of mental disorders in the
interval: ... the goal of validating these syndromes and discov-
ering common etiologies has remained elusive. ... [N]ot one
laboratory marker has been found to be specific in identifying
146
Clinical Social Work and the Biomedical Industrial Complex
any of the DSM-defined syndromes (Kupfer, First, & Regier,
2002, pp. xviii-xix).
The Chair of the DSM-1V Task Force, Allen Frances (2009),
repeated the assessment verbatim when commenting on the
upcoming DSM-V slated for publication in 2013:
The incredible recent advances in neuroscience,
molecular biology, and brain imaging . . . are still
not relevant to the clinical practicalities of everyday
psychiatric diagnosis. The clearest evidence supporting
this disappointing fact is that not even one biological
test is ready for inclusion in the criteria sets for DSM-V.
(p. 1)
Building on the lack of gold standard validity for DSM cat-
egories, a compelling conceptual and empirical literature criti-
cal of the DSM has accumulated in all the helping disciplines.
The DSM's criteria for distinguishing mental disorder from
normality are critiqued for being undefined and tautological
(Jacobs & Cohen, 2004, 2010), and the manual is faulted for
having impoverished the study of distress and misbehavior
(Andreasen, 2007), for emphasizing the diagnosis rather than
the client's story (Tucker, 1998), for the marginal improve-
ments in reliability produced by the DSM-III and successors
(Kirk & Kutchins, 1994), for its categories' lack of fit with ob-
served distress in individuals (Mirowsky & Ross, 2003), for its
persistent gender and class biases (Caplan & Cosgrove, 2004),
for the frankly political processes by which categories are in-
cluded or excluded from it (Caplan, 1995), and for the financial
ties between the pharmaceutical industry and DSM Task Force
members (Cosgrove, Krimsky, Vijayaraghavan, & Schneider,
2006).
Despite the consensus concerning the fragile scientific
basis of the DSM and its mostly cultural and political accom-
plishments, a content analysis of 69 syllabi of psychopathology
courses in schools of social work found that only six (8.5%) as-
signed any literature which critiqued the reliability and valid-
ity of the DSM (Lacasse & Gomory, 2003). This is ironic, since
the two strongest critics of the DSM are social work academics
Stuart Kirk and Herbert Kutchins, who have argued in many
articles and books that the much-touted improvements in
147
Journal of Sociology & Social Welfare
reliability promised by the DSM rest on "flawed, incomplete-
ly reported, and inconsistent" evidence, and that the DSM's
success can only be understood by analyzing "the politics and
management of science" (1992, pp. 15-16). No scholarly work
has invalidated this critique; it has only grown substantially.
The DSM nonetheless remains the only well-accepted tool
for billing mental health services, which makes sense given its
functions in the psychiatric-industrial complex. It is published
by the profession officially owning the problem of mental
illness, which it defines. It enables the conduct of clinical trials
which are predicated on the existence of distinct mental dis-
orders-for which the FDA grants pharmaceutical firms an
exclusive patent to market branded psychoactive drugs, most
of which reap revenues in excess of $1 billion per year shortly
after marketing. A DSM diagnosis also serves as a necessary
condition for a wide range of services and resources, especial-
ly as federal funding for social services decreases and that for
health services increases (Smith, 2010). For these reasons, the
manual serves both as economic incentive and constraint on
mental health professionals (Kirk & Kutchins, 1988). In a recent
survey of clinical social workers, 86% stated they gave a DSM
diagnosis "often to always," 94% citing insurance reimburse-
ment as the main reason to do so (Frazer et al., 2009), with half
of respondents stating that they would not use the DSM if they
were not required to do so. Despite its profound limitations
and its completely uncertain benefits for the day-to-day work
of helping distressed clients (Caplan & Cosgrove, 2004), the
DSM remains an indispensable component of the technology
and education of the helping professions for one reason: it re-
flects a medical view of distress and misbehavior.
Psychiatric Medications and
the Pharmaceutical Industry
The biomedical model holds that distress and misbehavior
are bodily diseases and must be treated as such. Supporters
of the model promote it as objective scientific knowledge.
Believing that the model is valid has important political and
economic ramifications, including broadened rationales for
forced treatment (since disease implies non-responsibility) and
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allocating public resources for palliating distress according to
medical or psychiatric criteria (Olsen, 2000). Importantly, the
model has helped to consolidate the pharmaceutical industry
as the leading player in the mental health system. In turn, the
industry promotes the model as naturally suited to the con-
cerns of the professions and the public. This has been a boon
to expand markets for branded drugs, and drugs' popularity
in turn promotes the legitimacy of the model and relieves its
adherents from producing the hard evidence needed to vali-
date it scientifically. Despite extremely dubious contributions
of drugs in improving indicators of mental distress in compari-
son to the pre-drug era (Healy, 2008; Whitaker, 2010), it remains
controversial to question the status of a drug prescription as
the paradigmatic healing intervention in mental health.
Consider the case of the antipsychotic drugs. These have
been the primary psychiatric treatment for psychosis since the
1950s. When their extraordinarily burdensome adverse effects
and limited longer-term therapeutic benefits became too con-
sequential to ignore-and useful to emphasize in promoting
the next wave of drugs-a group of second-generation, or
atypical, drugs was introduced starting in 1989 and promoted
to clinicians and patients as a decisive advance in the treat-
ment of schizophrenia. However, their clinical trials were filled
with deliberate confounds, which made assessing the drugs'
utility difficult (Cohen, 2002). Duplicate data were published
in multiple articles, confusing the picture of how many clients
had been studied and inflating the drugs' perceived efficacy
(Huston & Moher, 1996). When manufacturers detected prob-
lems-such as the tendency of olanzapine to cause extreme
weight gain-they withheld the information and claimed the
contrary (Dyer, 2007). They made concerted efforts to influence
physicians to prescribe the drugs for off-label purposes (Brody,
2007) by individual detailing and continuing education activi-
ties, while researchers enmeshed in financial conflicts of interest
created "evidence-based guidelines" recommending the drugs
(Healy, 2006). The industry also provided generous funding to
groups such as the National Alliance for Mental Illness (NAMI)
(NAMI received 75% of its total donations from 2006 through
2008, or $23 million, from this source), which in turn has advo-
cated tirelessly for liberal public funding of the drugs (Harris,
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2009). From less than $1 billion in 1995, sales of antipsychot-
ics in the United States rose to an astounding $11.5 billion in
2006 (Wilson, 2009), with Medicaid apparently paying for 69%
(Waters, 2007), mostly for off-label prescriptions for which the
FDA had not considered any clinical trials and for which the
drugs had not been approved.
In 2005, the large NIMH-funded Clinical Antipsychotic
Trials of Intervention Effectiveness (CATIE) trial found that
the generic 1950s drug perphenazine (about 9 a dose) was as
efficacious as the newer antipsychotics (about $9 a dose) and
that all antipsychotics tested were discontinued on average by
74% of clients before the 18-month study ended (Lieberman
et al., 2005). Furthermore, the newer medications offered no
superior quality-of-life (Jones et al., 2006). Commenting on his
profession's lapse in the evaluation of the newer antipsychot-
ics, Lieberman (2006) acknowledged:
The claims of superiority for the [atypicals] were greatly
exaggerated. This may have been encouraged by an
overly expectant community of clinicians and patients
eager to believe in the power of new medications. At the
same time, the aggressive marketing of these drugs may
have contributed to this enhanced perception of their
effectiveness in the absence of empirical information.
(p. 1070)
Discussing the findings' ramifications for public policy and
spending, Rosenheck, Leslie, and Doshi (2008) contextualized
the annual spending on the newer antipsychotics:
... the additional cost of using these [rather than older
drugs] ... is substantially greater than the $8.5 billion
total income of all 47,000 U.S. psychiatrists ... , could
fund 150,000 case managers [for] 1.5 million additional
consumers-or could support three times the total
number of social workers currently employed in the
United States. (p. 516)
In 2008 and 2009, several states and the Federal government
launched suits against drugmaker Eli Lilly for illegal market-
ing of Zyprexa (olanzapine) and other drugs for off-label indi-
cations, resulting in the largest corporate fine in U.S. history,
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$1.4 billion. Observers were quick to note that Zyprexa's sales
that year alone were over $4 billion. By mid-2009, major fines
had been imposed on the makers of most atypical antipsychot-
ics on the market (i.e., Feeley & Fisk, 2010; Kmietowicz, 2009;
Tanne, 2010).
In recent years, books about psychoactive medications
have appeared in the social work literature (e.g., Austrian,
2005; Bentley & Walsh, 2006, Dziegielewski & Leon, 2001).
By and large, these writings strongly affirm the therapeutic
value of currently promoted medications and suggest how
social workers can facilitate their use. None of these writ-
ings, however, have analyzed the scientific or political basis
for psychiatry's unrestrained promotion of pharmacological
treatment, for example, by scrutinizing randomized controlled
trials or examining how the pharmaceutical industry influ-
ences physicians. In all these texts, claims for the advantages
of the second-generation antipsychotics are repeated without
any critical analysis. Similar presentations are made for all
newer classes of psychotropics, which seems extraordinary,
given that the so-called pharmacological revolution in mental
health is now nearly 60 years old. Along the way, psychiat-
ric social workers did not object to the enormous transfer of
public funds to the pharmaceutical companies; we have found
no evidence that the issues described were considered by the
profession at large.
The majority of teenage foster children receive psychiatric
medications, with a sizeable minority receiving at least three
drugs per day (Zito et al., 2008). Children on Medicaid are four
times more likely to be prescribed antipsychotics than children
with private health insurance (Wilson, 2009). In child welfare,
tragic stories have emerged in which young children were
given cocktails of psychotropics died or committed suicide
(e.g., Rebecca Riley, 4 years old, Massachusetts; Gabriel Myers,
7 years old, Florida). In each of these two instances, social
workers were involved: they took children or their families to
doctors' appointments, diligently monitored the medication
intake, and even recorded drug-induced harm to the children
(Wen, 2010). Yet they had no power to effect any changes in
the systems in which they participated. These social workers
appeared to function as enforcers of a thoroughly medicalized
approach to family poverty, disorganization and distress, to
151
Journal of Sociology & Social Welfare
the detriment of the unfortunate children involved (see Florida
Department of Children and Families, 2009).
On a macro level, the NASW engages in political advocacy,
but has been silent on the promotion of drugs to consumers at
the expense of psychosocial treatment or prevention programs
(Lacasse, 2005). Moreover, in 2007, NASW took money from
Jannsen in exchange for the cooperation of NASW members
in a "research project" on a recently released injectable anti-
psychotic, which, it was argued, was actually a thinly veiled
marketing project (Clark, 2007; Cohen et al., 2007; Wong, 2007).
That a social work organization ostensibly committed to social
justice might fulfill the role of enabler of companies which are
increasingly shown to be America's worst corporate citizens
seems truly bizarre.
From the restriction of the practice of psychotherapy to
psychiatrists as medical doctors from about 1910-1950 (Abbott,
1988, p. 302) to the recent use of drug treatments, little appears
to have changed for social workers. Not permitted to perform
psychotherapy in those early days, they cannot prescribe medi-
cations today, yet their default stance is to encourage or require
that clients accept what psychiatrists prescribe. Social workers
might assume that, although lying outside their expertise, such
interventions are benevolent and beneficial. Psychiatrists are
conceded the intellectual/ideological higher ground, based on
their presumed grasp of yet-to-be-validated theories (psycho-
analysis previously, brain circuit imbalance theories of mental
disorders presently). Social workers benefit (in prestige and
salary) in both instances by supporting something medical,
but this requires them to construct the problem as a disease
inside the client, regardless of their ethical mandate and pro-
fessional socialization about systemic and person-in-environ-
ment approaches. Social workers are valued by psychiatrists
for their commitment to this model, and it is not surprising that
professionally they remain the handmaidens of psychiatry. Yet
when social workers tacitly agree with the biomedical model
of human problems, their clients not only enjoy the benefits
but also suffer the consequences of this naive commitment.
Arguably, psychiatry has been subsumed as a satellite
branch of the pharmaceutical industry, with most intellec-
tual and practical innovations centering on the introduc-
tion of new drugs, the popularization of new indications for
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existing drugs, and the expansion of DSM disorder categories
to fit drug prescription trends. Emboldened by generous finan-
cial support of its activities from the drug industry, psychiatry
presents its biomedical hypotheses in textbooks, articles, press
releases and government websites as established facts, conceal-
ing enormous definitional and logical contradictions and weak
empirical evidence for biological theories of mental disorders
(Boyle, 2002; Moncrieff, 2008; Pam, 1990, 1995; Read, Mosher,
& Bentall, 2004; Valenstein, 1998).
Material deprivation, poor parenting, interpersonal vio-
lence, and disorganized and decaying communities are strong-
ly correlated with emotional and behavioral disturbances
(Hollingshead & Redlich, 1958; Hudson, 2005; Read, van Os,
Morrison, & Ross, 2005), but the biomedical model concedes
only minor importance to these factors. Rather than striving to
improve human relationships or living conditions to prevent
and alleviate distress and psychosocial disability (Umberson &
Montez, 2010), the biomedical complex siphons off resources
to develop and distribute more psychoactive drugs.
Displacement of Primary Clinical Social Work Functions
While clinical social workers are engaged in studying, as-
sessing, and assigning DSM diagnoses or taking in biased ac-
counts of psychotropic medication effectiveness and convinc-
ing clients to take their medications, they are distracted from
applying and developing their own profession's quintessential
approaches to understanding, palliating, and preventing per-
sonal distress and maladjustment. Social work's person-in-envi-
ronment perspective provides an alternate framework for these
problems by focusing on: people's interpersonal, emotional,
educational, and material needs; harmful effects of depriva-
tion, abuse, and trauma; and the benefits of supportive social
relationships, self-awareness and self-regulation, constructive
thinking and problem-solving, and other coping mechanisms.
The social work perspective primarily lends itself to an advo-
cacy role in securing clients necessary resources and protecting
them from physical or psychological harm. This perspective
also is embodied in numerous, well-tested psychosocial in-
terventions that help clients to gain insight into their problem
situations, teach skills and alternative behaviors to deal with
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those problems, obtain familial and other social support to
encourage healthy life-styles, and, perhaps most crucial of
all, preventive or early intervention programs that preempt
mental problems before they develop or worsen. These ap-
proaches stand in stark contrast with reductionist, biomedical
theories that locate the cause of mental disturbances and focus
treatment almost entirely within clients' neurochemistry.
Considering treatments for clients diagnosed with severe
mental disorders as an example, social workers have applied
a variety of psychoeducational techniques, such as modeling,
verbal instructions, positive reinforcement, and environmen-
tal restructuring to effectively increase clients' normative be-
havior and to replace psychotic responses (Wong, 1996; Wong,
Wilder, Schock, & Clay, 2004). Using cognitive-behavioral
therapy (CBT) that emphasized stress reduction and coping
strategies, social work professor William Bradshaw and his
associates (Bradshaw, 2003; Bradshaw & Roseborough, 2004)
produced large effect-size improvements in psychosocial func-
tioning and similar magnitude reductions in severity of symp-
toms in patients with long histories of being diagnosed with
schizophrenia. Bradshaw's findings are partially corroborated
by results of meta-analyses showing moderately positive out-
comes of CBT for persons diagnosed with schizophrenia in
other clinical studies (Pilling et al., 2002; Wykes, Steel, Everitt,
& Tarrier, 2008). Cognitive enhancement therapy, a social-cog-
nitive intervention, has shown impressive results in clients
recently diagnosed with DSM-IV defined schizophrenia (Eack
et al., 2009). Social work researchers have also reanalyzed
outcome data and noted the successful treatment of persons
with acute psychosis in small, home-like, community-based
programs operated by nonprofessional staff with minimal
use of antipsychotic medications (Bola & Mosher, 2003; Bola,
Mosher, & Cohen, 2005).
These effective community-based programs offer a less re-
strictive and less costly alternative to confinement in mental
hospitals or psychiatric units of medical-surgical hospitals.
This evidence is bolstered further by evidence from an early
psychosis psychotherapy intervention program in Lapland,
Finland, which has been effective in modifying the course of
psychosis (Seikkula et al., 2000, 2006) and which likely even
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lowers the prevalence of DSM-IV defined schizophrenia
(Whitaker, 2010), an outcome seemingly beyond reach of our
current mental health system in the U.S. However, it will be
very difficult for social workers to improve psychosocial ser-
vices or deliver them to a broader span of clients as existing
mental health services, funding, and research are all centered
on a view of psychosis, severe distress and maladjustment as
developmental brain disease and the accompanying psycho-
pharmacological treatments (Wong, 2006).
Another important approach to addressing psychosocial
distress, disability, and disapproved behavior applicable by
social workers is prevention or early intervention. Similar to
public health programs that prevent the outbreak of diseases
by promoting proper sanitation, healthy diet, vaccinations,
avoidance of toxins, and other methods, preventive mental
health programs aim to reduce participants' exposure to risk
factors and to teach participants skills to counter potentially
harmful behaviors. By intervening before problems have
become serious or have caused irreparable damage, preventive
interventions can be more humane, less expensive, have neg-
ligible adverse effects, and hold greater potential for reducing
the overall prevalence of psychosocial distress in the general
population than any type of treatment-after-the-fact (Albee &
Gullotta, 1997; Ammerman & Hersen, 1997; Blair, 1992).
A few social work researchers are taking the lead in formu-
lating prevention and early intervention programs to preempt
the development of psychosocial problems that are precursors
to severe mental disturbances and finding evidence of effica-
cy. Fraser and his colleagues (Fraser, Day, Galinsky, Hodges,
& Smokowski, 2004) used a randomized design to demon-
strate the effectiveness of in-home, parent training and child
social skills training to increase children's prosocial behavior,
improve self-regulation of emotions, increase contact with
peers, raise concentration and perseverance on classroom tasks,
and to reduce aggression towards other children. Hawkins
and associates (2009) conducted a large-scale controlled evalu-
ation across 24 towns in 7 states of similar skills-building pro-
grams for youth and adolescents aimed at preventing alcohol,
tobacco, and other drug use (correlated with severe mental
disorders) and delinquent behavior. These investigators found
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statistically significant lower rates of drug use and delinquent
behavior in youth participating in the prevention programs.
In a series of studies, Lecroy designed a psychoeducational
prevention program for adolescent girls to promote appro-
priate gender role, positive body image, independent deci-
sion-making, assertiveness, improved peer relationships, and
seeking help when it is needed (Lecroy, 2004a, 2004b). In one
phase of his research, Lecroy (2004b) used a randomized design
to evaluate his program and found statistically significant dif-
ferences in favor of the intervention group in five out of eight
outcome measures.
While promising, these programs require substantial ad-
ditional research and refinement. For example, a more recent
meta-analysis of CBT applied to clients with a schizophrenia
diagnosis (Lynch, Laws, & McKenna, 2010) found results con-
tradicting Pilling et al. (2002) and Wykes et al. (2008). In addi-
tion, the favorable findings of the Hawkins et al. (2009) have
only been partially duplicated by other investigators (Feinberg,
Jones, Greenberg, Osgood, & Bontempo, 2010; Haggerty,
Skinner, MacKenzie, & Catalano, 2007), and the statistically
significant differences obtained by Lecroy did not have large
effect sizes (Lecroy, 2004b). Nevertheless, these psychoso-
cial prevention and treatment programs-which controlled
studies have shown to directly benefit clients and their com-
munities-deserve considerably more attention and commit-
ment from social workers, rather than the heavily advertised
and possibly toxic pharmaceuticals that are already omnipres-
ent in our society.
Conclusion
We have argued that social work, early on in its profes-
sional existence, identified with psychiatry, these two profes-
sions becoming "tied to the most fundamental of society's
functions, the control of those who are identified as deviant.
The poor, the insane, the criminal, the dependent... The
possibility of injustice in such a function is clear enough"
(Reid, 1992, p. 40). We have also highlighted that, as a result
of its allegiance to institutional psychiatry, social work has
become over the past generation inextricably entangled in the
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biomedical/psychiatric industrial complex. Its medicalized
and coercive worldview has become the professional air clini-
cal social workers breathe, making it difficult to even notice
some of the adverse consequences raised by this uncritical
cooperation. Despite the scientific failure of the medical ap-
proach to reduce human distress and misbehavior to any caus-
ative biological state, it claims an ever-greater share of public
funding to treat human distress and misbehavior as biological
diseases.
A challenge to our perspective is that the biomedical
complex provides attractive jobs for many social workers
and its ideology dominates nearly all mental health agencies.
Nevertheless, despite inducements and pressures to conform
to the biomedical doctrine, social workers must confront the
issues discussed here if they are to preserve their integrity as
members of an independent profession. It seems crucial that
social work education implement, to borrow a phrase from
Reeser and Leighninger (1990), a "specialization in social
justice." Using the moral, political, and economic beliefs with
which they resonate, students should be helped to articulate
their own vision of a just society, learn how to analyze the po-
litical, economic, and social structures of society and under-
stand how these can oppress people, and empower themselves
to reduce or counter the influence of institutions that mislead
and oppress. Moreover, students should be helped to envision
and build the sorts of economic and political structures that
place clients' interests at the top of social workers' priority
lists. They should also develop the sort of open-mindedness
that will maintain a constantly vigilant reexamination of their
own roles within the mental health system and the empirical
claims promulgated under it. It would be naive to think that
human distress and misbehavior could be vanquished by any
socio-economic or therapeutic project, but it would be more
naive and misguided to act as an obedient ancillary profession
marching to the drumbeat of a rapacious biomedical industrial
complex.
References
Abbott, A. D. (1988). The system of professions: An essay on the division of
expert labor. Chicago, IL: The University of Chicago Press.
157
Journal of Sociology & Social Welfare
Albee, G. W., & Gullotta, T. P. (Eds.). (1997). Primary prevention works.
Thousand Oaks, CA: Sage.
Alexander, L. B. (1972). Social work's Freudian deluge: Myth or
reality? Social Service Review, 46, 517-538.
Ammerman, R. T., & Hersen, M. (Eds.). (1997). Handbook of prevention
and treatment with children and adolescents. New York, NY: John
Wiley & Sons.
Andreasen, N. C. (2007). DSM and the death of phenomenology in
America: An example of unintended consequences. Schizophrenia
Bulletin, 33, 108-112.
Austrian, S. G. (2005). Mental disorders, medications, and clinical social
work (3rd ed.). New York, NY: Columbia University Press.
Bentley, K. J., & Walsh, J. F. (2006). The social worker and psychotropic
medications: Toward effective collaboration with mental health clients,
families, and providers (3rd ed.). Belmont, CA: Thomson Brooks/
Cole.
Bielefeld, W., & Chu, J. (2010). Foundations and social welfare in the
twentieth century. In H. K. Anheier & D. C. Hammack (Eds.),
American foundations: Roles and contributions (pp. 158-181).
Washington, DC: The Brookings Institution.
Blair, A. (1992). The role of primary prevention in mental health
services: A review and critique. Journal of Community & Applied
Social Psychology, 2, 77-94
Bola, J. R., & Mosher, L. R. (2003). Treatment of acute psychosis
without neuroleptics: Two-year outcomes from the Soteria
Project. Journal of Nervous and Mental Disease, 191, 219-229.
Bola, J. R., Mosher, L. R., & Cohen, D. (2005). Treatment of newly
diagnosed psychosis without antipsychotic drugs: The Soteria
Project. In S. A. Kirk (Ed.), Mental disorders in the social environment:
Critical perspectives (pp. 368-384). New York, NY: Columbia
University Press.
Bond, G. R., Drake, R. E., Mueser, K. T., & Latimer, E. (2001). Assertive
community treatment: Critical ingredients and impact on
patients. Disease Management and Health Outcomes, 9(3), 141-159.
Bourdon, K. H., Rae, D. S., Narrow, W. E., Manderscheid, R. W.,
& Regier, D. A. (1994). National prevalence and treatment of
mental and addictive disorders. In R. W. Manderscheid & M. A.
Sonnenschein (Eds.), Mental health, United States, 1994 (pp. 22-51).
Washington, DC: Superintendent of Documents, U.S. Goverment
Printing Office.
Boyle, M. (2002). Schizophrenia: A scientific delusion? (2nd ed.). London:
Routledge.
Bradshaw, W. (2003). Use of single-system research to evaluate the
effectiveness of cognitive-behavioural treatment of schizophrenia.
British Journal of Social Work, 33, 885-899.
Bradshaw, W., & Roseborough, D. (2004). Evaluating the effectiveness
of cognitive-behavioral treatment of residual symptoms and
impairment in schizophrenia. Research in Social Work Practice,
14(2), 112-120.
158
Clinical Social Work and the Biomedical Industrial Complex
Breggin, P. R. (1997). Brain disabling treatments in psychiatry: Drugs,
electroshock, and the role of the FDA. New York, NY Springer.
Brody, J. (2007). Hooked: Ethics, the medical profession and the
pharmaceutical industry. Lanham, MD: Rowman and Littlefield.
California Health & Human Services Agency. (2009). Involuntary
detention data: Fiscal year 2006-07. CA: California Health and
Human Services Agency, Department of Mental Health.
Caplan, P. J. (1995). They say you're crazy: How the world's most powerful
psychiatrists decide who's normal. Boston, MA: Perseus.
Caplan, P. J., & Cosgrove, L. (Eds.). (2004). Bias in psychiatric diagnosis.
New York, NY: Jason Aronson.
Carpenter, M. (2001). It's a small world: Mental health policy under
welfare capitalism since 1945. In J. Busfield (Ed.), Rethinking the
sociology of mental health (pp. 58-75). Oxford: Blackwell.
Cassels, A. (2009). Ponziceuticals within the medical industrial
complex. Canadian Medical Association Journal, 181, 1-2.
Christy, A. (2007). The Florida Mental Health Act (Baker Act) 2007
annual report. Tampa, FL: Louis de la Parte Florida Mental Health
Institute, University of South Florida.
Clark, E. (2007, May). Social work must be at the table. NASW News,
54(5), 3.
Cohen, D. (2002). Research on the drug treatment of schizophrenia:
A critical appraisal and implications for social work education.
Journal of Social Work Education, 38, 217-239.
Cohen, D. (2010). Psychopharmacology and clinical social work
practice. In J. R. Brandell (Ed.), Theory and practice of clinical social
work (2nd ed., pp. 763-810). Newbury Park, CA: Sage.
Cohen, D., and 19 signatories. (2007). Open letter to NASW regarding
"Adherence Initiative for Schizophrenia." Retrieved from www.
manufacturedconsensus.net.
Conrad, P. (2007). The medicalization of society: On the transformation
of human conditions into treatable disorders. Baltimore, MD: Johns
Hopkins University Press.
Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L.
(2006). Financial ties between DSM-IV panel members and the
pharmaceutical industry. Psychotherapy and Psychosomatics, 75,
154-160.
Dolnick, E. (1998). Madness on the couch: Blaming the victim in the
heyday of psychoanalysis. New York, NY: Simon & Schuster.
Duhl, L. J., Cummings, N. A., & Hynes, J. J. (1987). The emergence
of the mental health complex. In L. J. Duhl & N. A. Cummings
(Eds.), The future of mental health services: Coping with crisis (pp.
1-14). New York, NY: Springer.
Dyer, 0. (2007). Lilly investigated in US over the marketing of
olanzapine. BMJ (What does this stand for?), 334, 171.
Dziegielewski, S. F., & Leon, A. M. (2001). Social work practice and
psychopharmacology. New York, NY: Springer.
159
Journal of Sociology & Social Welfare
Eack, S. M., Greenwald, D. P., Hogarty, S. S., Cooley, S. J., DiBarry,
A. L., Montrose, D. M., & Keshavan, M. S. (2009). Cognitive
enhancement therapy for early-course schizophrenia: Effects of a
two-year randomized controlled trial. Psychiatric Services, 60(11),
1468-1476.
Feeley, J., & Fisk, M. C. (2010, October 14). Johnson and Johnson must
pay Louisiana $257.7 million over Risperdal marketing practices.
Bloomberg News. Retrieved October 18, 2010 from http:/ /tinyurl.
com/26awovg.
Fenton, W. S., Mosher, L. R., Herrell, J. M., & Blyler, C. R. (1998).
Randomized trial of general hospital and residential alternative
care for patients with severe and persistent mental illness.
American Journal of Psychiatry, 155, 516-522.
Feinberg, M. E., Jones, D., Greenberg, M. T., Osgood, D. W., &
Bontempo, D. (2010). Effects of the Communities That Care
Model in Pennsylvania on change in adolescent risk and problem
behaviors. Prevention Science, 11, 163-171.
Florida Department of Children and Families. (2009). Report of
Gabriel Myers workgroup. Retrieved May 28, 2010 from http:/ /
www.dcf.state.fl.us /initiatives / GMWorkgroup / docs /
GabrielMyersWorkGroupReport082009Final.pdf.
Frances, A. (2009, June 26). A warning sign on the road to DSM-V:
Beware of its unintended consequences. Psychiatric Times, 1-6.
Fraser, M. W., Day, S. H., Galinsky, M., Hodges, V., & Smokowski, P.
R. (2004). Preventing youth violence: A single-blind, randomized
trial of a multi-element program for aggressive, rejected children
in elementary school. Research on Social Work Practice, 13, 1-22.
Frazer, P., Westhuis, D., Daley, J. G., & Phillips, I. (2009). How clinical
social workers are using the DSM-IV: A national study. Social
Work in Mental Health, 7, 325-339.
Gollaher, D. (1995). Voice for the mad: The lfe of Dorothea Dix. New
York, NY The Free Press.
Gomory, T. (2005). Assertive community treatment (ACT): The case
against the "best tested" evidence-based community treatment
for severe mental illness. In S. A. Kirk (Ed.), Mental disorders in the
social environment: Critical perspectives (pp. 165-189). New York,
NY Columbia University Press.
Greenfield, T. K., Stoneking, B. C., Humphreys, K., Sundby, E., &
Bond, J. (2008). A randomized trial of a mental health consumer-
managed alternative to civil commitment for acute psychiatric
crisis. American Journal of Community Psychology, 42, 135-144.
Grob, G. N. (1973). Mental institutions in America: Social policy to 1875.
New York, NY: The Free Press.
Grob, G. N. (1994). The mad among us: A history ofAmerica's mentally ill.
Cambridge, MA: Harvard University Press.
Haggerty, K. P., Skinner, M. L., MacKenzie, E. P., & Catalano, R. F.
(2007). A randomized trial of Parents Who Care: Effects on key
outcomes at 24-month follow-up. Prevention Science, 8, 249-260.
160
Clinical Social Work and the Biomedical Industrial Complex 161
Harris, G. (2009, October 21). Drug makers are advocacy group's
biggest donors. New York Times. Retrieved from: http://www.
nytimes.com/2009/10/22/health/22nami. html.
Hawkins, J. D., Oesterle, S., Brown, E. C., Arthur, M. W., Abbott,
R. D., Fagan, A. A., & Catalano, R. F. (2009). Results of a type 2
translational research trial to prevent adolescent drug use and
delinquency. Archives of Pediatrics & Adolescent Medicine, 163(9),
789-798.
Healy, D. (2006). Manufacturing consensus. Culture, Medicine and
Psychiatry, 30(2), 135-156.
Healy, D. (2008). Mania: A short history of bipolar disorder. Baltimore,
MD: Johns Hopkins University Press.
Hollingshead, A. d. B., & Redlich, F. C. (1958). Social class and mental
illness: A community study. New York, NY: Wiley.
Hudson, C. G. (2005). Socioeconomic status and mental illness: Tests
of the social causation and selection hypotheses. American Journal
of Orthopsychiatry, 75, 3-18.
Huston, P., & Moher, D. (1996). Redundancy, disaggregation, and the
integrity of medical research. Lancet, 347, 1024-1026.
Hutchinson, E. D. (1992). Competing moral values and use of social
work authority with involuntary clients. In P. N. Reid & P. R.
Popple (Eds.), The moral purposes of social work: The character and
intentions of a profession (pp. 120-140). Chicago, IL: Nelson-Hall
Inc.
Jacobs, D. H., & Cohen, D. (2004). Hidden in plain sight: DSM-IV's
rejection of the categorical approach to diagnosis. Review of
Existential Psychology & Psychiatry, 26(2-3), 81-96.
Jacobs, D. H., & Cohen, D. (2010). Does "psychological dysfunction"
mean anything? A critical essay on pathology vs. agency. Journal
of Humanistic Psychology, 50, 312-334.
Jones, P. B., Barnes, T. R., Davies, L., Dunn, G., Lloyd, H., Hayhurst,
K. P., et al. (2006). Randomized controlled trial of the effect on
quality of life of second- vs. first-generation antipsychotic drugs
in schizophrenia: Cost utility of the latest antipsychotic drugs in
schizophrenia study (CUTLASS-1). Archives of General Psychiatry,
63, 1079-1087.
Kiesler, C. A., & Sibulkin, A. E. (1987). Mental hospitalization: Myths
and facts about a national crisis. Newbury Park, CA: Sage.
Kiesler, C. A., & Simpkins, C. G. (1993). The unnoticed majority in
psychiatric inpatient care. New York, NY: Plenum.
Kirk, S. A., & Kutchins, H. (1988). Deliberate misdiagnosis in mental
health practice. Social Service Review, 62, 225-237.
Kirk, S. A., & Kutchins, H. (1992). The selling of DSM: The rhetoric of
science in psychiatry. New York, NY: Aldine De Gruyter.
Kirk, S. A., & Kutchins, H. (1994). The myth of the reliability of DSM.
Journal of Mind and Behavior, 15(1&2), 71-86.
Kirk, S. A., Siporin, M., & Kutchins, H. (1989). The prognosis for
social work diagnosis. Social Casework, 70(5), 295-304.
Journal of Sociology & Social Welfare
Klerman, G. (1978). The evolution of a scientific nosology. In J.C.
Shershaw (Ed.), Schizophrenia: Science and practice (pp. 99-121).
Cambridge, MA: Harvard University Press.
Kmietowicz, Z. (2009). Eli Lilly pays record $1.4bn for promoting off-
label use of olanzapine. British Medical Journal, 338, b217.
Kupfer, D. J., First, M. B., & Regier, D. A. (2002). A research agenda for
DSM-V Washington, DC: American Psychiatric Association.
Lacasse, J. R. (2005). Consumer advertising of psychiatric medications
biases the public against non-pharmacological treatment. Ethical
Human Psychology and Psychiatry, 7, 175-179.
Lacasse, J. R., & Gomory, T. (2003). Is graduate social work education
promoting a critical approach to mental health practice? Journal
of Social Work Education, 39, 383-408.
Lecroy, C. W. (2004a). Evaluation of an empowerment program for
early adolescent girls. Adolescence, 39, 427-441.
Lecroy, C. W. (2004b). Experimental evaluation of "Go Grrrls"
preventive intervention for early adolescent girls. Journal of
Primary Prevention, 25, 457-473.
Leiby, J. (1978). A history of social welfare and social work in the United
States. New York, NY: Columbia University Press.
Levit, K. R., Kassed, C. A., Coffey, R. M., Mark, T. L., Stranges, E. M.,
Buck, J. A., & Vandivort-Warren, R. (2008). Future funding for
mental health and substance abuse: Increasing burdens for the
public health sector. Health Affairs, 27(6), w513-w522.
Lieberman, J. A. (2006). Comparative effectiveness of antipsychotic
drugs. Archives of General Psychiatry, 63, 1069-1072.
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M.S., Rosenheck,
R. A., Perkins, D.O., et al. (2005). Effectiveness of antipsychotic
drugs in patients with chronic schizophrenia. New England
Journal of Medicine, 353, 1209-1223.
Lightner, D. L. (1999). Asylum, prison, and poor house: The writing and
reform work of Dorothea Dix in Illinois. Carbondale, IL: Southern
Illinois University Press.
Lloyd-Evans, B., Slade, M., Jagielska, D., & Johnson, S. (2009).
Residential alternatives to acute psychiatric hospital admission:
Systematic review. British Journal of Psychiatry, 195, 109-117.
Lubove, R. (1983). The professional altruist. New York, NY: Atheneum.
(Original work published 1965).
Lynch, D., Laws, K. R., & McKenna, P. J. (2010). Cognitive behavioural
therapy for major psychiatric disorder: Does it really work? A
meta-analytical review of well-controlled trials. Psychological
Medicine, 40,9-24.
Manderscheid, R. W., & Berry, J. T. (Eds.). (2006). Mental Health, United
States, 2004. Rockville, MD: Substance Abuse and Mental Health
Services Administration.
Margolin, L. (1997). Under the cover of kindness: The invention of social
work. Charlottesville, VA: University Press of Virginia.
162
Clinical Social Work and the Biomedical Industrial Complex
Mechanic, D. (1990). Deinstitutionalization: An appraisal of reform.
Annual Review of Sociology, 16, 301-327.
Mirowsky, J., & Ross, C. E. (2003). Social causes of psychological distress
(2nd ed.). New York, NY: Walter de Gruyter.
Moncrieff, J. (2008). The myth of the chemical cure: A critique ofpsychiatric
drug treatment. New York, NY: Palgrave MacMillan.
Moynihan, R., & Cassels, A. (2005). Selling sickness. Vancouver, BC:
Douglas & McIntyre.
Murray, T. L. (2009). The loss of client agency into the
psychopharmaceutical-industrial complex. Journal of Mental
Health Counseling, 31, 283-408.
National Association of Social Workers. (2005). NASW standards
for clinical social work in social work practice. Washington, DC:
Author.
Olsen, D. P. (2000). Policy implications of the biological model of
mental disorder. Nursing Ethics, 7, 412-424.
Pam, A. (1990). A critique of the scientific status of biological
psychiatry. Acta Psychiatrica Scandinavica, 82(Suppl. 362), 1-35.
Pam, A. (1995). Biological psychiatry: Science or pseudoscience? In
C. A. Ross & A. Pam (Eds.), Pseudoscience in biological psychiatry
(pp. 7-84). New York, NY: John Wiley & Sons.
Pfeiffer, S. I. (1990). An analysis of methodology in follow-up studies
of adult inpatient psychiatric treatment. Hospital and Community
Psychiatry, 41, 1315-1321.
Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Orbach, G.,
& Morgan, C. (2002). Psychological treatments in schizophrenia:
Meta-analysis of family intervention and cognitive behaviour
therapy. Psychological Medicine, 32, 763-782.
Pottick, K., Hansell, S., Gaboda, D., & Gutterman, E. (1993). Child and
adolescent outcomes of inpatient psychiatric services: A research
agenda. Children and Youth Services Review, 15, 371-384.
Read, J., Mosher, L., & Bentall, R. (Eds). (2004). Models of madness:
Psychological, social, and biological approaches to schizophrenia. New
York, NY: Brunner-Routledge.
Read, J., van Os, J., Morrison, A. P., & Ross, C. A. (2005). Childhood
trauma, psychosis and schizophrenia: A literature review with
theoretical and clinical implications. Acta Psychiatrica Scandinavica,
112, 330-350.
Reamer, F G. (1992). Social work and the public good: Calling or
career? In P. N. Reid & P. R. Popple (Eds.), The moral purposes of
social work: The character and intentions of a profession (pp. 11-33).
Chicago: Nelson-Hall Inc.
Reid, P. N. (1992). The social function and social morality of social
work: A utilitarian perspective. In P. N. Reid & P. R. Popple
(Eds.), The moral purposes of social work: The character and intentions
of a profession (pp. 34-50). Chicago: Nelson-Hall Inc.
163
Journal of Sociology & Social Welfare
Reeser, L. C., & Leighninger, L. (1990). Back to our roots: Toward
a specialization in social justice. Journal of Sociology and Social
Welfare, 17(2), 69-87.
Relman, A. S. (1980). The new medical-industrial complex. New
England Journal of Medicine, 303, 963-970.
Richmond, M. (1917). Social diagnosis. New York, NY: Russell Sage
Foundation.
Rothman, D. J. (1990). The discovery of the asylum. Boston, MA: Little,
Brown.
Rosenheck, R. A., Leslie, D. L., & Doshi, J. A. (2008). Second-generation
antipsychotics: Cost effectiveness, policy options, and political
decision making. Psychiatric Services, 59, 515-520.
Scull, A. (1981). Madhouses, mad-doctors, and madmen: The social history
of psychiatry in the Victorian era. Philadelphia, PA: University of
Pennsylvania Press.
Seikkula, J., Alakre, B., Aaltonen, J., Holma, J., Rasinkangas, A.,
& Lehtinen, V. (2003). Open dialogue approach: Treatment
principles and preliminary results of a two-year follow-up on
first-episode schizophrenia. Ethical Human Sciences and Services,
5(3), 163-182.
Seikkula, J., Aaltonen, J., Alakare, B., Haarakangas, K., Keranen,
J., & Lehtinen, K. (2006). Five-year experience of first-episode
nonaffective psychosis in open-dialogue approach: Treatment
principles, follow-up outcomes, and two case studies.
Psychotherapy Research, 16(2), 214-228.
Sledge, W. H., Tebes, J., Rakfeldt, J., Davidson, L., Lyons, L., & Druss,
B. (1996). Day hospital/crisis respite care versus inpatient care,
Part I: Clinical outcomes. American Journal of Psychiatry, 153,
1065-1073.
Smith, S. R. (2010). The political economy of contracting and
competition. In Y. Hasenfeld (Ed.), Human services as complex
organizations (2nd ed., pp. 139-160). Thousand Oaks, CA: Sage.
Tanne, J. H. (2010). AstraZeneca pays $520m fine for off label
marketing. British Medical Journal, 340, c2380.
Trattner, W. I. (1979). From poor law to welfare state: A history of social
welfare in America (2nd ed.). New York, NY: Free Press.
Tucker, G. J. (1998). Putting DSM-IV in perspective. American Journal
of Psychiatry, 155, 159-161.
Turnock, B. J. (2009). Public health: What it is and how it works (4th ed).
Boston: Jones & Bartlett.
Umberson, D., & Montez, J. K. (2010). Social relationships and health:
A flashpoint for health policy. Journal of Health and Social Behavior,
51, S54-S66.
United States Bureau of Labor Statistics. (2010). Occupational outlook
handbook, 2010-2011 edition. Retrieved October 10, 2010, from
http://www.bls.gov/oco/ocos060.htm.
164
Clinical Social Work and the Biomedical Industrial Complex
Valenstein, E. S. (1998). Blaming the brain: The truth about drugs and
mental health. New York, NY: The Free Press.
Walsh, J., Green, R., Matthews, J., & Bonucelli-Puerto, B. (2005). Social
workers' views of the etiology of mental disorders: Results of a
national study. Social Work, 50, 43-52.
Waters, R. (2007, September 27). Lilly's Zyprexa poised for approval
for U.S. teens. Bloomberg News. Retrieved from http://www.
bloomberg.com.
Wen, P. (2010, January 21). Social worker warned that Rebecca
Riley, 4, was overmedicated. Boston Globe. Retrieved May 28,
2010 from http:/ /www.boston.com/news/local/breaking
news/2010/01/socialworker w.html.
Whitaker, R. (2002). Mad in America. Cambridge, MA: Perseus
Publishing.
Whitaker, R. (2010). Anatomy of an epidemic: Magic bullets, psychiatric
drugs, and the astonishing rise of mental illness in America. New
York, NY: Crown.
Whitaker, T., & Arrington, P. (2008). Professional development. NASW
Membership Workforce Study. Washington, DC: National
Association of Social Workers.
Wilson, D. (2009, December 12). Poor children likelier to get
antipsychotics. New York Times, Al.
Wong, S. E. (1996). Psychosis. In M. Mattaini & B. A. Thyer (Eds.),
Finding solutions to social problems: Behavioral strategies for change
(pp. 319-343). Washington, DC: American Psychological
Association.
Wong, S. E. (2006). Behavior analysis of psychotic disorders: Scientific
dead end or casualty of the mental health political economy?
Behavior and Social Issues, 15, 152-177.
Wong, S. E. (2007, May). Psychotropic meds [Letter to the Editor].
NASW News, 54(5), 3.
Wong, S. E., Wilder, D. A., Schock, K., & Clay, C. (2004). Behavioral
interventions with severe and persistent mental disorders. In H.
E. Briggs & T. L. Rzepnicki (Eds.), Using evidence in social work
practice: Behavioral perspectives (pp. 210-230). Chicago, IL: Lyceum
Books.
Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2008). Cognitive
behavior therapy for schizophrenia: Effect sizes, clinical models,
and methodological rigor. Schizophrenia Bulletin, 34(3), 523-527.
Zito, J. M., Safer, D. J., Devadatta, S., Gardner, J. F., Thomas,
D., Coomges, P., Dubowski, M. & Medez-Lewis, M. (2008).
Psychotoropic medication patterns among youth in foster care.
Pediatrics, 121, el57-el63.
165

